GAVISCON EXTRA STRENGTH BUTTERSCOTCH FLAVOURED TABLETS 400 MG — DIN 02230582
ALGINIC ACID : 400 MG ALUMINUM HYDROXIDE : 160 MG · SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is GAVISCON EXTRA STRENGTH BUTTERSCOTCH FLAVOURED TABLETS?
GAVISCON EXTRA STRENGTH BUTTERSCOTCH FLAVOURED TABLETS 400 MG contains ALGINIC ACID : 400 MG ALUMINUM HYDROXIDE : 160 MG. It is listed in the Health Canada Drug Product Database under DIN 02230582, held by SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 25-Aug-1998. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Alginic Acid in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
8 holders have a Canadian DIN containing Alginic Acid, across 22 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | 8 | 0 | GAVISCON BUTTERSCOTCH FLAVOUR TABLETS, GAVISCON EXTRA STRENGTH BUTTERSCOTCH FLAVOURED TABLETS, GAVISCON EXTRA STRENGTH STRAWBERRY FL.TABS, GAVISCON HEARTBURN RELIEF TABLETS, GAVISCON ICY MINT FLAVOUR LIQ, +3 more | No marketed DIN |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 3 | 0 | GAVISCON EXTRA STRENGTH TABLETS, GAVISCON TABLETS, TUMS DUAL ACTION | No marketed DIN |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 3 | 0 | MAALOX HRF SUSPENSION, MAALOX HRF TABLETS | No marketed DIN |
| FERRING INC | 2 | 0 | RAFTON LIQUID - FRUIT FLAVOUR, RAFTON TABLETS - FRUIT FLAVOUR | No marketed DIN |
| RHONE-POULENC RORER CONSUMER INC. | 2 | 0 | MAALOX HRF SUSPENSION, MAALOX HRF TABLETS | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 2 | 0 | GASTROCOTE CHEWABLE TAB, HEARTBURN RELIEF - TAB | No marketed DIN |
| STERLING WINTHROP INC. | 1 | 0 | GAVISCON HEARTBURN RELIEF LIQUID | No marketed DIN |
| VITA HEALTH PRODUCTS INC | 1 | 0 | HEARTBURN RELIEF | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 400 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Alginic Acid |
|---|---|
| ATC code | A02BX13 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02230582 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2230582 |
| Brand name | GAVISCON EXTRA STRENGTH BUTTERSCOTCH FLAVOURED TABLETS |
| Generic / active ingredient | ALGINIC ACID : 400 MG ALUMINUM HYDROXIDE : 160 MG |
| Market authorization holder | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02BX13 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02BX |
| Current status | CANCELLED POST MARKET |
| Status date | 25-Aug-1998 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 22 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| GASTROCOTE CHEWABLE TAB | 80 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 01941879 |
| GAVISCON BUTTERSCOTCH FLAVOUR TABLETS | 200 MG | TABLET | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02159813 |
| GAVISCON EXTRA STRENGTH STRAWBERRY FL.TABS | 160 MG | TABLET | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02159805 |
| GAVISCON EXTRA STRENGTH TABLETS | 400 MG | TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | CANCELLED POST MARKET | 02230581 |
| GAVISCON HEARTBURN RELIEF LIQUID | 100 MG / 5 ML | LIQUID | STERLING WINTHROP INC. | CANCELLED POST MARKET | 02085720 |
| GAVISCON HEARTBURN RELIEF TABLETS | 40 MG | TABLET | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02142651 |
| GAVISCON ICY MINT FLAVOUR LIQ | 250 MG / 5 ML | LIQUID | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02159767 |
| GAVISCON LIQUID - FRUIT & MINT FLAVOURS | 100 MG / 5 ML | LIQUID | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02142643 |
| GAVISCON TABLETS | 200 MG | TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | CANCELLED POST MARKET | 02159783 |
| GAVISCON TABLETS - BUTTERSCOTCH AND FR.FL. | 80 MG | TABLET | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02142627 |
2 · Same class — other molecules in ATC A02BX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Sucralfate | APO-SUCRALFATE - TAB 1G · DOM-SUCRALFATE · NU-SUCRALFATE - TAB 1GM · PMS-SUCRALFATE · +5 more | 9 | 4 | Yes |
| Alginic Acid | GASTROCOTE CHEWABLE TAB · GAVISCON BUTTERSCOTCH FLAVOUR TABLETS · GAVISCON EXTRA STRENGTH BUTTERSCOTCH FLAVOURED TABLETS · GAVISCON EXTRA STRENGTH STRAWBERRY FL.TABS · +15 more | 22 | 0 | Not in Canada |
| Pirenzepine | GASTROZEPIN TAB 50MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A02B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A02BC | Dexlansoprazole · Esomeprazole · Lansoprazole · Omeprazole · Pantoprazole · +1 more | 288 | 108 |
| A02BA | Cimetidine · Famotidine · Famotidine, Combinations · Nizatidine · Ranitidine · +1 more | 235 | 26 |
| A02BB | Misoprostol | 10 | 2 |
| A02BD | Bismuth Subcitrate,Tetracycline And Metronidazole · Lansoprazole, Amoxicillin And Clarithromycin | 3 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is GAVISCON EXTRA STRENGTH BUTTERSCOTCH FLAVOURED TABLETS called?
Also recorded in Canada as: alginic acid 200 MG / calcium carbonate 80 MG / magnesium trisilicate 20 MG / sodium bicarbonate 70 MG Oral Tablet (US), potassium bicarbonate 20 MG/ML / sodium alginate 100 MG/ML Oral Suspension (US), ALGINIC ACID (GLOBAL), ALGINIC ACID (US), ALGINIC ACID (UK), GAVISCON (US), GAVISCON (UK), GAVISCON (EU), GAVISCON (IN), ALGICON (UK), ALGINATE (GLOBAL).
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.